Citation: J. Leor et al., IS IT SAFE TO PRESCRIBE DIGOXIN AFTER ACUTE MYOCARDIAL-INFARCTION - UPDATE ON CONTINUED CONTROVERSY, The American heart journal, 130(6), 1995, pp. 1322-1326
Authors:
LEOR J
GOLDBOURT U
RABINOWITZ B
KAPLINSKY E
BEHAR S
Citation: J. Leor et al., DOES DIGOXIN EXERT ADVERSE EFFECT ON SURVIVORS OF MYOCARDIAL-INFARCTION - THE IMPORTANCE OF DIGOXIN DOSE, Journal of the American College of Cardiology, 1994, pp. 10000113-10000113
Authors:
LEOR J
GOLDBOURT U
BEHAR S
KAPLINSKY E
RABINOWITZ B
Citation: J. Leor et al., IS IT SAFE TO PRESCRIBE DIGOXIN TO PATIENTS RECOVERED FROM MYOCARDIAL-INFARCTION - OBSERVATIONS IN PATIENTS AT LOW AND INTERMEDIATE RISK, Journal of the American College of Cardiology, 1994, pp. 10000413-10000413
Authors:
BEHAR S
KAPLINSKY E
ZION M
REICHERREISS H
LEOR J
PALANT A
PELED B
SCHLESINGER Z
ABINADER E
FRIEDMAN Y
BARZILAI J
KISHON Y
REISIN L
ZAHAVI I
AGMON J
GOLDBOURT U
Citation: S. Behar et al., THE LONG-TERM PROGNOSTIC-SIGNIFICANCE OF HIGH-GRADE VENTRICULAR ECTOPIC ACTIVITY IN SURVIVORS OF ACUTE MYOCARDIAL-INFARCTION, American journal of noninvasive cardiology, 8(5), 1994, pp. 282-288
Authors:
VARDABLOOM N
LEOR J
OHAD D
KAMINER R
BATTLER A
ELDAR M
HASSIN D
Citation: N. Vardabloom et al., CYTOTOXIC T-LYMPHOCYTES ARE STIMULATED AFTER MYOCARDIAL-INFARCTION AND ARE ABLE TO RECOGNIZE AND KILL HEALTHY MYOCYTES IN-VITRO, Circulation, 90(4), 1994, pp. 522-522
Authors:
VARDABLOOM N
LEOR J
OHAD D
KAMINER R
BATTLER A
ELDAR M
HASSIN D
Citation: N. Vardabloom et al., CYTOTOXIC T-LYMPHOCYTES ARE STIMULATED AFTER MYOCARDIAL-INFARCTION AND ARE ABLE TO RECOGNIZE AND KILL HEALTHY MYOCYTES IN-VITRO, Circulation, 90(4), 1994, pp. 522-522
Authors:
LEOR J
VARDABLOOM N
HASDAI D
OVADIA Z
BATTLER A
Citation: J. Leor et al., FAILURE OF CAPTOPRIL TO ATTENUATE MYOCARDIAL DAMAGE, NEUTROPHIL ACCUMULATION, AND MORTALITY FOLLOWING CORONARY-ARTERY OCCLUSION AND REPERFUSION IN RAT, Angiology, 45(8), 1994, pp. 717-724
Authors:
LEOR J
ROTSTEIN Z
VERED Z
KAPLINSKY E
TRUMAN S
ELDAR M
Citation: J. Leor et al., ABSENCE OF TACHYCARDIA DURING TILT TEST PREDICTS FAILURE OF BETA-BLOCKER THERAPY IN PATIENTS WITH NEUROCARDIOGENIC SYNCOPE, The American heart journal, 127(6), 1994, pp. 1539-1543
Authors:
LEOR J
FEINBERG MS
VERED Z
HOD H
KAPLINSKY E
GOLDBOURT U
TRUMAN S
MOTRO M
Citation: J. Leor et al., EFFECT OF THROMBOLYTIC THERAPY ON THE EVOLUTION OF SIGNIFICANT MITRALREGURGITATION IN PATIENTS WITH A 1ST INFERIOR MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 21(7), 1993, pp. 1661-1666